Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab with or without Sargramostim in Advanced Melanoma
NCT01134614Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Dec 2010
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in melanoma, sponsored by National Cancer Institute. Started Dec 2010; status: active, not recruiting.
02
Drugs
sargramostim
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01134614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134614.